128 related articles for article (PubMed ID: 33185810)
1. Establishment and optimization of a high-throughput mimic perfusion model in ambr
Jin L; Wang ZS; Cao Y; Sun RQ; Zhou H; Cao RY
Biotechnol Lett; 2021 Feb; 43(2):423-433. PubMed ID: 33185810
[TBL] [Abstract][Full Text] [Related]
2. Scale-down model qualification of ambr® 250 high-throughput mini-bioreactor system for two commercial-scale mAb processes.
Manahan M; Nelson M; Cacciatore JJ; Weng J; Xu S; Pollard J
Biotechnol Prog; 2019 Nov; 35(6):e2870. PubMed ID: 31207168
[TBL] [Abstract][Full Text] [Related]
3. Development of a novel, high-throughput screening tool for efficient perfusion-based cell culture process development.
Gagliardi TM; Chelikani R; Yang Y; Tuozzolo G; Yuan H
Biotechnol Prog; 2019 Jul; 35(4):e2811. PubMed ID: 30932357
[TBL] [Abstract][Full Text] [Related]
4. ambr
Warr SRC
Methods Mol Biol; 2020; 2095():43-67. PubMed ID: 31858462
[TBL] [Abstract][Full Text] [Related]
5. Characterization of TAP Ambr 250 disposable bioreactors, as a reliable scale-down model for biologics process development.
Xu P; Clark C; Ryder T; Sparks C; Zhou J; Wang M; Russell R; Scott C
Biotechnol Prog; 2017 Mar; 33(2):478-489. PubMed ID: 27977912
[TBL] [Abstract][Full Text] [Related]
6. High throughput automated microbial bioreactor system used for clone selection and rapid scale-down process optimization.
Velez-Suberbie ML; Betts JPJ; Walker KL; Robinson C; Zoro B; Keshavarz-Moore E
Biotechnol Prog; 2018 Jan; 34(1):58-68. PubMed ID: 28748655
[TBL] [Abstract][Full Text] [Related]
7. Platform development for high-throughput optimization of perfusion processes-Part II: Variation of perfusion rate strategies in microwell plates.
Dorn M; Lucas C; Klottrup-Rees K; Lee K; Micheletti M
Biotechnol Bioeng; 2024 Jun; 121(6):1774-1788. PubMed ID: 38433473
[TBL] [Abstract][Full Text] [Related]
8. A novel scale-down mimic of perfusion cell culture using sedimentation in an automated microbioreactor (SAM).
Kreye S; Stahn R; Nawrath K; Goralczyk V; Zoro B; Goletz S
Biotechnol Prog; 2019 Sep; 35(5):e2832. PubMed ID: 31050211
[TBL] [Abstract][Full Text] [Related]
9. Application of high-throughput mini-bioreactor system for systematic scale-down modeling, process characterization, and control strategy development.
Janakiraman V; Kwiatkowski C; Kshirsagar R; Ryll T; Huang YM
Biotechnol Prog; 2015; 31(6):1623-32. PubMed ID: 26317495
[TBL] [Abstract][Full Text] [Related]
10. Scale-Down Model Development in ambr systems: An Industrial Perspective.
Sandner V; Pybus LP; McCreath G; Glassey J
Biotechnol J; 2019 Apr; 14(4):e1700766. PubMed ID: 30350921
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome analysis for the scale-down of a CHO cell fed-batch process.
Alsayyari AA; Pan X; Dalm C; van der Veen JW; Vriezen N; Hageman JA; Wijffels RH; Martens DE
J Biotechnol; 2018 Aug; 279():61-72. PubMed ID: 29800599
[TBL] [Abstract][Full Text] [Related]
12. Semi-continuous scale-down models for clone and operating parameter screening in perfusion bioreactors.
Bielser JM; Domaradzki J; Souquet J; Broly H; Morbidelli M
Biotechnol Prog; 2019 May; 35(3):e2790. PubMed ID: 30773840
[TBL] [Abstract][Full Text] [Related]
13. Spectroscopy integration to miniature bioreactors and large scale production bioreactors-Increasing current capabilities and model transfer.
Rowland-Jones RC; Graf A; Woodhams A; Diaz-Fernandez P; Warr S; Soeldner R; Finka G; Hoehse M
Biotechnol Prog; 2021 Jan; 37(1):e3074. PubMed ID: 32865874
[TBL] [Abstract][Full Text] [Related]
14. Automation of high CHO cell density seed intensification via online control of the cell specific perfusion rate and its impact on the N-stage inoculum quality.
Schulze M; Lemke J; Pollard D; Wijffels RH; Matuszczyk J; Martens DE
J Biotechnol; 2021 Jul; 335():65-75. PubMed ID: 34090946
[TBL] [Abstract][Full Text] [Related]
15. Development of a shake tube-based scale-down model for perfusion cultures.
Wolf MKF; Lorenz V; Karst DJ; Souquet J; Broly H; Morbidelli M
Biotechnol Bioeng; 2018 Nov; 115(11):2703-2713. PubMed ID: 30039852
[TBL] [Abstract][Full Text] [Related]
16. Development and application of a high-throughput platform for perfusion-based cell culture processes.
Villiger-Oberbek A; Yang Y; Zhou W; Yang J
J Biotechnol; 2015 Oct; 212():21-9. PubMed ID: 26197419
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a fully automated microtiter plate-based system for suspension cell culture and its application for enhanced process optimization.
Markert S; Joeris K
Biotechnol Bioeng; 2017 Jan; 114(1):113-121. PubMed ID: 27399304
[TBL] [Abstract][Full Text] [Related]
18. Principles and approach to developing mammalian cell culture media for high cell density perfusion process leveraging established fed-batch media.
Lin H; Leighty RW; Godfrey S; Wang SB
Biotechnol Prog; 2017 Jul; 33(4):891-901. PubMed ID: 28371394
[TBL] [Abstract][Full Text] [Related]
19. Optimizing performance of semi-continuous cell culture in an ambr15™ microbioreactor using dynamic flux balance modeling.
Kelly W; Veigne S; Li X; Subramanian SS; Huang Z; Schaefer E
Biotechnol Prog; 2018 Mar; 34(2):420-431. PubMed ID: 29152911
[TBL] [Abstract][Full Text] [Related]
20. Bioreactor productivity and media cost comparison for different intensified cell culture processes.
Xu S; Gavin J; Jiang R; Chen H
Biotechnol Prog; 2017 Jul; 33(4):867-878. PubMed ID: 27977910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
